Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 16, 1978
The five-year survival rate in urban patients with ovarian carcinomaR W Rush, M B Bennett, C VaderSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 28, 1975
Fetal and early neonatal mortalityA F Malan, C Vader, V K KnutzenJournal of Personalized Medicine|December 24, 2021
miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular EdemaMaartje J C Vader, Yasmin I Habani, Reinier O Schlingemann, et al.Investigative Ophthalmology & Visual Science|June 2, 2025
Several Common Genetic Variations Associate With Functional or Anatomic Effects of Anti-VEGF Treatment in Conditions With Macular EdemaIngeborg Klaassen, Maartje J C Vader, Khadija Aissa, et al.British Journal of Cancer|August 16, 2017
GNAQ and GNA11 mutations and downstream YAP activation in choroidal neviM J C Vader, M C Madigan, M Versluis, et al.Ophthalmology. Retina|May 5, 2020
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized TrialMaartje J C Vader, Ann-Sofie M E Schauwvlieghe, Frank D Verbraak, et al.Ophthalmology. Retina|February 29, 2020
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized TrialMaartje J C Vader, Ann-Sofie M E Schauwvlieghe, Frank D Verbraak, et al.Pageof 1